Glenmark Pharma Cuts Price of Covid-19 Drug FabiFlu by 27% to Rs 75 per Tablet

Glenmark has also completed the phase 3 clinical trial with Favipiravir (FabiFlu) in mild to moderate COVID-19 patients in India. The trial results will be available shortly, the company said.

from Top India News- News18.com https://ift.tt/308xn8O